Antibacterial	0	12
properties	14	23
of	25	26
dermaseptin	28	38
S4	40	41
derivatives	43	53
under	55	59
extreme	61	67
incubation	69	78
conditions	80	89
.	90	90

Antibacterial	92	104
properties	106	115
of	117	118
the	120	122
frog	124	127
-	128	128
derived	129	135
peptide	137	143
dermaseptin	145	155
S4	157	158
and	160	162
a	164	164
series	166	171
of	173	174
synthetic	176	184
derivatives	186	196
against	198	204
the	206	208
food	210	213
pathogen	215	222
Escherichia	224	234
coli	236	239
O157	241	244
:	245	245
H7	246	247
were	249	252
investigated	254	265
under	267	271
extreme	273	279
incubation	281	290
conditions	292	301
.	302	302

The	304	306
28	308	309
-	310	310
mer	311	313
analog	315	320
K4K20S4	322	328
(	330	330
P28	331	333
)	334	334
displayed	336	344
an	346	347
MIC	349	351
of	353	354
8	356	356
microM	358	363
and	365	367
rapid	369	373
bactericidal	375	386
kinetics	388	395
under	397	401
standard	403	410
culture	412	418
conditions	420	429
.	430	430

Potent	432	437
bactericidal	439	450
properties	452	461
were	463	466
maintained	468	477
at	479	480
high	482	485
salt	487	490
concentrations	492	505
,	506	506
under	508	512
acidic	514	519
or	521	522
basic	524	528
conditions	530	539
,	540	540
and	542	544
at	546	547
extreme	549	555
temperatures	557	568
.	569	569

The	571	573
N	575	575
-	576	576
terminal	577	584
14	586	587
-	588	588
mer	589	591
sequence	593	600
(	602	602
P14	603	605
)	606	606
displayed	608	616
higher	618	623
potency	625	631
(	633	633
MIC	634	636
,	637	637
4	639	639
microM	641	646
)	647	647
but	649	651
only	653	656
within	658	663
a	665	665
narrow	667	672
range	674	678
of	680	681
incubation	683	692
conditions	694	703
,	704	704
pointing	706	713
to	715	716
the	718	720
importance	722	731
of	733	734
the	736	738
C	740	740
-	741	741
terminal	742	749
domain	751	756
of	758	759
P28	761	763
.	764	764

The	766	768
potency	770	776
range	778	782
was	784	786
reextended	788	797
upon	799	802
conjugation	804	814
of	816	817
aminododecanoic	819	833
acid	835	838
to	840	841
P14	843	845
.	846	846

The	848	850
resulting	852	860
lipopeptide	862	872
was	874	876
even	878	881
more	883	886
potent	888	893
(	895	895
MIC	896	898
,	899	899
2	901	901
microM	903	908
)	909	909
and	911	913
affected	915	922
bacterial	924	932
viability	934	942
under	944	948
most	950	953
of	955	956
the	958	960
conditions	962	971
tested	973	978
,	979	979
including	981	989
in	991	992
commercial	994	1003
apple	1005	1009
juice	1011	1015
.	1016	1016

The	1018	1020
mechanistic	1022	1032
implications	1034	1045
of	1047	1048
peptides	1050	1057
'	1058	1058
hydrophobicity	1060	1073
,	1074	1074
charge	1076	1081
,	1082	1082
structure	1084	1092
,	1093	1093
and	1095	1097
binding	1099	1105
to	1107	1108
an	1110	1111
idealized	1113	1121
membrane	1123	1130
were	1132	1135
probed	1137	1142
and	1144	1146
are	1148	1150
discussed	1152	1160
here	1162	1165
.	1166	1166

Collectively	1168	1179
,	1180	1180
the	1182	1184
data	1186	1189
indicate	1191	1198
interest	1200	1207
in	1209	1210
simple	1212	1217
peptide	1219	1225
-	1226	1226
based	1227	1231
compounds	1233	1241
for	1243	1245
design	1247	1252
of	1254	1255
antimicrobials	1257	1270
that	1272	1275
affect	1277	1282
pathogens	1284	1292
under	1294	1298
a	1300	1300
variable	1302	1309
range	1311	1315
of	1317	1318
incubation	1320	1329
conditions	1331	1340
.	1341	1341
